---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-098685"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:45:11.868341+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics CFO Hunt becomes sole principal financial officer; VP Austin departs

## Summary
- Mark Austin ceased as VP of Finance, Corporate Controller, Corporate Secretary, and co-principal financial officer on August 16, 2024.
- CFO Jonathan Hunt (age 57) now serves as sole principal financial officer and principal accounting officer.
- No arrangements, family relationships, or interested transactions exist between Hunt and the company or its officers.

## SEC filing metadata
- accession: 0000950170-24-098685
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/catx-20240816.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-098685
- JSON: https://secwatch.observer/filing/0000950170-24-098685.json
- Plain text: https://secwatch.observer/filing/0000950170-24-098685.txt

## Key facts
- Executive change
  Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..
  - Action: designated
  - Role: Chief Financial Officer
  source text: Effective as of the Effective Date, Jonathan Hunt, the Company’s Chief Financial Officer and “co-principal financial officer,” began serving as the Company’s sole “principal financial officer” and “principal accounting officer.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm
- Executive change
  Mark Austin resigned as Vice President of Finance, Corporate Controller and Corporate Secretary at Perspective Therapeutics, Inc..
  - Action: resigned
  - Role: Vice President of Finance, Corporate Controller and Corporate Secretary
  source text: On August 16, 2024 (the “ Effective Date ”), Mark Austin, the Vice President of Finance, Corporate Controller and Corporate Secretary of Perspective Therapeutics, Inc. (the “ Company ”), ceased serving as an executive officer and as the Company’s “co-principal financial officer” and “principal accounting officer.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.